Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Pu

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
Oncotarget|February 10, 2018
Specific alterations in gut microbiota are associated with prognosis of Budd-Chiari syndromeYu-Ling Sun, Wen-Qi Li, Peng-Xu Ding, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|October 26, 2007
[Epidemiologic study on STD/HIV infections among tin mining workers in Gejiu, Yunnan province]Guo-lei Zhang, Ning Wang, Jun-jie Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutininYi Pu Lin, Xiaoli Xiong, Stephen A Wharton, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 10, 2025
Muscle Structure and Function Recovery: Adalimumab-Calcium Channel Synergy in Post-Ischemic Stroke SarcopeniaHu Qi, Xiong-Wei Zhang, Ze-Yang Zhang, et al.
Vaccines|February 24, 2024
Quantitative Analysis of the Instant and Persistent Inhibition Effects of Maternal Poliovirus Antibodies on the Immune Response in a Phase IV Trial of a Sabin Strain-Based Inactivated Poliovirus VaccineQiongzhou Yin, Yan Zheng, Zhifang Ying, et al.
Virology|April 8, 2011
Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particlesVincent Moulès, Olivier Terrier, Matthieu Yver, et al.
Vaccine|February 22, 2024
Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18-24 Months: A phase Ⅳ clinical trialQiongzhou Yin, Yan Zheng, Zhifang Ying, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibodyXiaoli Xiong, Davide Corti, Junfeng Liu, et al.
Nature Communications|June 4, 2026
Molecular glue that stabilizes the LRPPRC-MET-G4 interaction complex to drive MET downregulationYi-Pu Li, Ying Zheng, Yu-Shuang Liu, et al.
Vaccine|January 25, 2021
Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large populationRuiju Jiang, Xiaoqiang Liu, Xiaodong Sun, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Oncotarget|February 10, 2018
Specific alterations in gut microbiota are associated with prognosis of Budd-Chiari syndromeYu-Ling Sun, Wen-Qi Li, Peng-Xu Ding, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|October 26, 2007
[Epidemiologic study on STD/HIV infections among tin mining workers in Gejiu, Yunnan province]Guo-lei Zhang, Ning Wang, Jun-jie Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutininYi Pu Lin, Xiaoli Xiong, Stephen A Wharton, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 10, 2025
Muscle Structure and Function Recovery: Adalimumab-Calcium Channel Synergy in Post-Ischemic Stroke SarcopeniaHu Qi, Xiong-Wei Zhang, Ze-Yang Zhang, et al.
Vaccines|February 24, 2024
Quantitative Analysis of the Instant and Persistent Inhibition Effects of Maternal Poliovirus Antibodies on the Immune Response in a Phase IV Trial of a Sabin Strain-Based Inactivated Poliovirus VaccineQiongzhou Yin, Yan Zheng, Zhifang Ying, et al.
Virology|April 8, 2011
Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particlesVincent Moulès, Olivier Terrier, Matthieu Yver, et al.
Vaccine|February 22, 2024
Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18-24 Months: A phase Ⅳ clinical trialQiongzhou Yin, Yan Zheng, Zhifang Ying, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibodyXiaoli Xiong, Davide Corti, Junfeng Liu, et al.
Nature Communications|June 4, 2026
Molecular glue that stabilizes the LRPPRC-MET-G4 interaction complex to drive MET downregulationYi-Pu Li, Ying Zheng, Yu-Shuang Liu, et al.
Vaccine|January 25, 2021
Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large populationRuiju Jiang, Xiaoqiang Liu, Xiaodong Sun, et al.
Pageof 25